Invention Grant
US08623864B2 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
有权
用于逆转抗微生物药物抗性的硫利达嗪及其衍生物
- Patent Title: Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
- Patent Title (中): 用于逆转抗微生物药物抗性的硫利达嗪及其衍生物
-
Application No.: US10579112Application Date: 2004-11-15
-
Publication No.: US08623864B2Publication Date: 2014-01-07
- Inventor: Jørn B. Christensen , Oliver Hendricks , Jette Kristiansen
- Applicant: Jørn B. Christensen , Oliver Hendricks , Jette Kristiansen
- Applicant Address: unknown Egernsund
- Assignee: NOA Sic Aps
- Current Assignee: NOA Sic Aps
- Current Assignee Address: unknown Egernsund
- Agency: Merchant & Gould P.C.
- Priority: DK200301690 20031113
- International Application: PCT/IB2004/003730 WO 20041115
- International Announcement: WO2005/046694 WO 20050526
- Main IPC: A61K31/54
- IPC: A61K31/54

Abstract:
The present invention relates to compositions comprising thioridazine, and derivatives thereof, together with antibacterials. These compositions have been found greatly enhance the activity of many classes of antibacterials, allowing the antibacterials to be administered at significantly lower doses. The thioridazine and the antibacterial act synergistically by pacifying the bacteria to the antibacterials. This synergistic affect lowering the inhibitory or effective concentration of the antimicrobials is most pronounced with the levorotatory isomer of thioridazine compared to the racemic or dextrorotatory isomer.
Public/Granted literature
- US20070287702A1 Thioridazine And Derivatives Thereof For Reversing Anti-Microbial Drug-Resistance Public/Granted day:2007-12-13
Information query